Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples
Awarded Limited / Sole Source Justification Posted
A later notice was posted: the Limited / Sole Source Justification from .
- Solicitation number
- 75A50120R00053
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75A50121P00002 Federal contract award
- Awardee
- Battelle Memorial Institute
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Columbus OH 43201 USA
Notice details come from SAM.gov. Updated .
About this opportunity
This Limited/Sole Source Justification Notice from the Department of Health and Human Services establishes a high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of up to 30 million human serum samples. Due to the urgent need to address the COVID-19 national public health emergency, HHS requires supplies and services with an estimated total value of $30 billion under a class justification and approval to facilitate recovery efforts. The contract was awarded to an unknown vendor on October 26, 2020 for an unknown amount, and has a period of performance not to exceed 12 months from the date of award.
Notice text
The Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human
Services (HHS) seeks to establish a high throughput SARS-CoV-2 high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples.
Awarded contract 75A50121P00002 to unknown vendor for unknown amount on 2020-10-26.
Files
| File | Type | Posted |
|---|---|---|
| Posted Class J and A_Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples | Limited / Sole Source Justification | |
| This notice | Limited / Sole Source Justification | |
| Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples | Award Notice | |
| Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples | Award Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity